Biotech · Private company
NervGen Pharma
Track this companyFree. Adds NervGen Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NVG-291Phase 3 · Chronic Spinal Cord InjuryClinicalTrials.gov · fetched Nov 12, 2026
- NVG-291Phase 2 · Spinal Cord InjuriesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord InjuryPHASE3 · RECRUITING · started Sep 28, 2026ClinicalTrials.gov NCT07799532 · fetched Nov 12, 2026
- NVG-291 in Spinal Cord Injury SubjectsPHASE1_PHASE2 · COMPLETED · started Aug 8, 2023ClinicalTrials.gov NCT05965700 · fetched Nov 12, 2026